|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Pre-analytical and analytical issues in the analysis of blood microparticles显示文摘 | Yuana Y Bertina RM Osanto S | 2011 | Thromb Haemost2011，105，： | 1 |
| 2 | Malignancies, prothrombotic mutations, and the risk of venous thrombosis显示文摘 | Blom JW Doggen CJ Osanto S | 2005 | JAMA2005，293，6： | 1 |
| 3 | Genome-Wide MicroRNA expression analysis of clear cell renal cell carcinoma by next generation deep sequencing显示文摘 | Osanto S Qin Y Buermans H P | 2012 | PLoS ONE2012，7，38： | 1 |
| 4 | Risk of venous thromboembolism in lung cancer显示文摘 | TESSELAAR M E OSANTO S | 2007 | Curt Opin Pulm Med2007，13，5： | 1 |
| 5 | Risk of venous thromboembolism in lung cancer显示文摘 | TESSELAAR ME OSANTO S | 2007 | Curt ()pin Pulm Med2007，13，5： | 1 |
| 6 | Malignancies, prothrom- botic mutations, and the risk of venous thrombosis 显示文摘 | Blom JW Doggen C J Osanto S | 2005 | JAMA2005，293，6： | 1 |
| 7 | Maligancies prothrombotic muttions and the risk of venous thromboembolism显示文摘 | Blom JW Doggen CJ Osanto S | 2005 | JAMA2005，293，： | 1 |
| 8 | Malignancies,prothrombotic mutations, and the risk of venous thrombosis 显示文摘 | BLOM JW DOGGEN CJ OSANTO S | 2005 | JAMA2005，293，6： | 1 |
| 9 | Emerging novel therapies for advanced prostate cancer显示文摘 | Osanto S Vanpoppel H | 2012 | Ther Adv Urol2012，4，1： | 1 |
| 10 | Malignancies, prothrombotic mutations, and the risk of venous thrombosis 显示文摘 | Blom JW Doggen CJ Osanto S | 2005 | JAMA2005，293，6： | 1 |
| 11 | Malignancies,prothromotic and the risk of venous thrombosis显示文摘 | Blom JW Doggen CJ Osanto S | | 0，，06： | 1 |
| 12 | Malignancies,prothrombotic muta- tions, and the risk ofvenous thrombosis显示文摘 | Blom JW Doggen CJ Osanto S | 2005 | JAMA2005，293，6： | 1 |
| 13 | Deep vein thrombo- sis associated with central venous catheters - a review显示文摘 | Rooden CJ Tesselaar ME Osanto S | 2005 | J Thromb Haemost2005，3，11： | 1 |
| 14 | Malignancies, pmthrombotic mutations,and the risk of venous thrombosis 显示文摘 | Blom JW Doggen C J Osanto S | 2005 | JAMA2005，293，6： | 1 |
| 15 | Malignancies, prothrombotic mutations and the risk of venous thrombosis显示文摘 | Bloom JW Doggen CJM Osanto S | 2005 | JAMA2005，，293： | 1 |
| 16 | Genome-wide microRNA expression analysis of clear cell renal cell carcinoma by next generation deep sequencing显示文摘 | Osanto S Qin Y Buermans HP Berkers J Lerut E Goeman JJ | | 0，，： | 1 |
| 17 | Risk of venous thromboembolism in lung cancer显示文摘 | Tesselaar ME Osanto S | 2007 | Currop in Pulm Med2007，13，5： | 1 |
| 18 | Malignancies,prothrombotic mutations,and the risk of venousthrombosis显示文摘 | Blom JW Doggen CJ Osanto S | | 0，，06： | 1 |
| 19 | The risk of a venous throm- boric event in lung cancer patients: higher risk for adenocarcino- ma than squamous cell carcinoma显示文摘 | BlomJW Osanto S Rosendaal FR | 2004 | J Thrombos Haemostas2004，2，10： | 1 |
| 20 | Malignancies, prothrom-botic mutations, and the risk of venous thrombosis 显示文摘 | Blom JW Doggen C J Osanto S | 2005 | JAMA2005，293，6： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员